Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,803 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples.
Barrett JE, Herzog C, Jones A, Leavy OC, Evans I, Knapp S, Reisel D, Nazarenko T, Kim YN, Franchi D, Ryan A, Franks J, Bjørge L, Zikan M, Cibula D, Harbeck N, Colombo N, Dudbridge F, Jones L, Sundström K, Dillner J, Rådestad AF, Gemzell-Danielsson K, Pashayan N, Widschwendter M. Barrett JE, et al. Among authors: jones a, jones l. Nat Commun. 2022 Feb 1;13(1):449. doi: 10.1038/s41467-021-27918-w. Nat Commun. 2022. PMID: 35105882 Free PMC article.
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
Bartlett TE, Evans I, Jones A, Barrett JE, Haran S, Reisel D, Papaikonomou K, Jones L, Herzog C, Pashayan N, Simões BM, Clarke RB, Evans DG, Ghezelayagh TS, Ponandai-Srinivasan S, Boggavarapu NR, Lalitkumar PG, Howell SJ, Risques RA, Rådestad AF, Dubeau L, Gemzell-Danielsson K, Widschwendter M. Bartlett TE, et al. Among authors: jones a, jones l. Genome Med. 2022 Jun 15;14(1):64. doi: 10.1186/s13073-022-01063-5. Genome Med. 2022. PMID: 35701800 Free PMC article. Clinical Trial.
Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
Bartlett TE, Evans I, Jones A, Barrett JE, Haran S, Reisel D, Papaikonomou K, Jones L, Herzog C, Pashayan N, Simões BM, Clarke RB, Evans DG, Ghezelayagh TS, Ponandai-Srinivasan S, Boggavarapu NR, Lalitkumar PG, Howell SJ, Risques RA, Rådestad AF, Dubeau L, Gemzell-Danielsson K, Widschwendter M. Bartlett TE, et al. Among authors: jones a, jones l. Genome Med. 2022 Jul 19;14(1):76. doi: 10.1186/s13073-022-01086-y. Genome Med. 2022. PMID: 35854342 Free PMC article. No abstract available.
Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
Roy-Luzarraga M, Abdel-Fatah T, Reynolds LE, Clear A, Taylor JG, Gribben JG, Chan S, Jones L, Hodivala-Dilke K. Roy-Luzarraga M, et al. Among authors: jones l. JAMA Netw Open. 2020 Oct 1;3(10):e2019304. doi: 10.1001/jamanetworkopen.2020.19304. JAMA Netw Open. 2020. PMID: 33107920 Free PMC article.
Field cancerization in breast cancer.
Gadaleta E, Thorn GJ, Ross-Adams H, Jones LJ, Chelala C. Gadaleta E, et al. J Pathol. 2022 Jul;257(4):561-574. doi: 10.1002/path.5902. Epub 2022 May 3. J Pathol. 2022. PMID: 35362092 Free PMC article. Review.
A review of the ethnic differences in breast cancer.
Bowen RL, Stebbing J, Jones LJ. Bowen RL, et al. Among authors: jones lj. Pharmacogenomics. 2006 Sep;7(6):935-42. doi: 10.2217/14622416.7.6.935. Pharmacogenomics. 2006. PMID: 16981851 Review.
SEARCHBreast Workshop Proceedings: 3D Modelling of Breast Cancer.
Morrissey B, Blyth K, Carter P, Chelala C, Holen I, Jones L, Speirs V. Morrissey B, et al. Among authors: jones l. Altern Lab Anim. 2015 Dec;43(6):367-75. doi: 10.1177/026119291504300604. Altern Lab Anim. 2015. PMID: 26753939
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer.
Patel H, Abduljabbar R, Lai CF, Periyasamy M, Harrod A, Gemma C, Steel JH, Patel N, Busonero C, Jerjees D, Remenyi J, Smith S, Gomm JJ, Magnani L, Győrffy B, Jones LJ, Fuller-Pace F, Shousha S, Buluwela L, Rakha EA, Ellis IO, Coombes RC, Ali S. Patel H, et al. Among authors: jones lj. Clin Cancer Res. 2016 Dec 1;22(23):5929-5938. doi: 10.1158/1078-0432.CCR-15-1104. Epub 2016 Jun 14. Clin Cancer Res. 2016. PMID: 27301701 Free PMC article.
Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study).
Packwood K, Martland G, Sommerlad M, Shaw E, Moutasim K, Thomas G, Bateman AC, Jones L, Haywood L, Evans DG, Birch JM, Alsalmi OA, Henderson A, Poplawski N, Eccles DM. Packwood K, et al. Among authors: jones l. J Pathol Clin Res. 2019 Jul;5(3):189-198. doi: 10.1002/cjp2.133. Epub 2019 May 23. J Pathol Clin Res. 2019. PMID: 31041842 Free PMC article.
8,803 results